Can I read Real-world Outcomes with Different Technology Modalities in Type 1 Diabetes on EtoBox?

Real-world Outcomes with Different Technology Modalities in Type 1 Diabetes by Pilar I. Beato-Víbora; Fabiola Gallego-Gamero; Ana Ambrojo-López is a Medicine article available to read on EtoBox.

What is Real-world Outcomes with Different Technology Modalities in Type 1 Diabetes about?

## Background and aims: Several treatment modalities are available for type 1 diabetes (t1d), including continuous glucose monitoring (cgm) and flash glucose monitoring (fgm) with mdi, sensor-augmented pumps with predictive low-glucose suspend function (sap-plgs) and hybrid closed-loop systems (hcl). the aim of the study was to evaluate the real-world benefits obtained with these treatment modalities. ## Methods and results: A cross-sectional study was performed, selecting 4 groups of t1d subjects, regarding their treatment modalities, paired by age, sex and diabetes duration. a comparison was performed, concerning time in different glucose ranges in 2-week sensor downloads. estimated hba1c, glycaemic variability measures and sensor use were also compared. 302 t1d people were included (age: 39 ± 12 years, 47% male, diabetes duration: 21 ± 10 years, estimated hba1c: 7.28 ± 0.84% (56 ± 9 mmol/mol), baseline hba1c: 7.4 ± 1.0% (57 ± 11 mmol/mol), length of use of the device 8 [3-21] months). group 1 (cgm + mdi) and 2 (fgm + mdi) showed no differences in time in different glucose ranges. group 4 (hcl) showed a higher time 70-180 mg/dl and a lower time in hypoglycaemia than group 3 (sap-

Who reads Real-world Outcomes with Different Technology Modalities in Type 1 Diabetes?

Author

Pilar I. Beato-Víbora; Fabiola Gallego-Gamero; Ana Ambrojo-López

Publisher

Elsevier BV

Published

2021

Language

EN

Field

Medicine (Health Sciences)